Is treatment with interferon-α effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions
Open Access
- 17 February 2004
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (4) , 794-799
- https://doi.org/10.1038/sj.bjc.6601622
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomialsStatistics in Medicine, 2004
- Metastatic renal carcinoma comprehensive prognostic systemBritish Journal of Cancer, 2003
- Subgroup analysis and other (mis)uses of baseline data in clinical trialsThe Lancet, 2000
- Therapeutic and Prognostic Implications of Peripheral Blood Lymphopenia in Patients with Hodgkin's DiseaseLeukemia & Lymphoma, 1999
- Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trialThe Lancet, 1999
- Building Multivariable Prognostic and Diagnostic Models: Transformation of the Predictors by Using Fractional PolynomialsJournal of the Royal Statistical Society Series A: Statistics in Society, 1999
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Regression Using Fractional Polynomials of Continuous Covariates: Parsimonious Parametric ModellingJournal of the Royal Statistical Society Series C: Applied Statistics, 1994
- Mechanism and Regulation of Natural CytotoxicityPathobiology, 1985